导管原位癌辅助放疗的省略：ECOG-ACRIN E5194试验的12年结果 - Suppr

[Omission of adjuvant radiotherapy in ductal carcinoma in situ : 12 year-results of the ECOG-ACRIN E5194-trial].

作者信息

Krug David, Souchon Rainer

机构信息

RadioOnkologie und Strahlentherapie, UniversitätsKlinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland.

, Berlin, Deutschland.

出版信息

Strahlenther Onkol. 2016 May;192(5):349-51. doi: 10.1007/s00066-016-0966-z.

DOI:10.1007/s00066-016-0966-z

PMID:27079672

Abstract

摘要

相似文献

[Omission of adjuvant radiotherapy in ductal carcinoma in situ : 12 year-results of the ECOG-ACRIN E5194-trial].导管原位癌辅助放疗的省略：ECOG-ACRIN E5194试验的12年结果

Strahlenther Onkol. 2016 May;192(5):349-51. doi: 10.1007/s00066-016-0966-z.

Is excision alone adequate treatment for low-risk ductal carcinoma-in-situ of the breast?单纯切除对于低风险乳腺导管原位癌来说是足够的治疗方法吗？

J Clin Oncol. 2006 Mar 1;24(7):1017-9. doi: 10.1200/JCO.2005.04.4610. Epub 2006 Feb 6.

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.不进行放疗的手术切除治疗乳腺导管原位癌：ECOG-ACRIN E5194研究的12年结果

J Clin Oncol. 2015 Nov 20;33(33):3938-44. doi: 10.1200/JCO.2015.60.8588. Epub 2015 Sep 14.

Local recurrence outcomes after breast conserving surgery and adjuvant radiotherapy in ductal carcinoma in situ of the breast and a comparison with ECOG E5194 study.保乳手术后及辅助放疗治疗乳腺导管原位癌的局部复发结果，并与 ECOG E5194 研究进行比较。

Breast. 2018 Dec;42:10-14. doi: 10.1016/j.breast.2018.08.094. Epub 2018 Aug 10.

Ipsilateral breast tumor recurrence after breast-conserving surgery for ductal carcinoma in situ.保乳手术后原位导管癌同侧乳腺肿瘤复发

Ann Surg. 2011 Jun;253(6):1233; author reply 1233-4. doi: 10.1097/SLA.0b013e31821c7ac5.

Random physician effect and comparative effectiveness of treatment for ductal carcinoma in situ.随机医生效应与导管原位癌治疗的比较疗效

J Natl Cancer Inst. 2011 Jan 19;103(2):81-2. doi: 10.1093/jnci/djq511. Epub 2011 Jan 3.

Predictors of local recurrence in a population-based cohort of women with ductal carcinoma in situ treated with breast conserving surgery alone.在接受单纯保乳手术治疗的导管原位癌女性患者的基于人群队列中，局部复发的预测因素。

Ann Surg Oncol. 2011 Jan;18(1):119-24. doi: 10.1245/s10434-010-1214-x. Epub 2010 Jul 20.

Re: Trends in the treatment of ductal carcinoma in situ of the breast.关于：乳腺导管原位癌的治疗趋势。

J Natl Cancer Inst. 2004 Aug 18;96(16):1258; author reply 1259-60. doi: 10.1093/jnci/djh249.

Part IV. Surgery for ductal carcinoma in situ.第四部分。导管原位癌的手术治疗。

Curr Probl Cancer. 2000 May-Jun;24(3):141-62. doi: 10.1016/s0147-0272(00)90015-1.

Local recurrence after partial mastectomy: relation to initial surgical margins.局部切除术后局部复发：与初始手术切缘的关系。

Am J Surg. 2011 Mar;201(3):374-8;discussion 378. doi: 10.1016/j.amjsurg.2010.09.024.

引用本文的文献

[Optimal margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ : Results of the ASTRO, ASCO, and SSO consensus guideline].[导管原位癌保乳手术联合全乳照射的最佳切缘：美国放射肿瘤学会（ASTRO）、美国临床肿瘤学会（ASCO）和美国乳腺外科医师学会（SSO）共识指南的结果]

Strahlenther Onkol. 2017 Oct;193(10):859-860. doi: 10.1007/s00066-017-1190-1.

本文引用的文献

Radiotherapy of Ductal Carcinoma In Situ.导管原位癌的放射治疗

Breast Care (Basel). 2015 Aug;10(4):259-64. doi: 10.1159/000437452. Epub 2015 Aug 19.

[Adjuvant radiotherapy significantly also reduces local recurrence rate for prognostically favorable DCIS].辅助放疗也显著降低了预后良好的导管原位癌的局部复发率。

Strahlenther Onkol. 2015 Dec;191(12):997-1000. doi: 10.1007/s00066-015-0906-3.

Addressing Overtreatment in DCIS: What Should Physicians Do Now?应对导管原位癌的过度治疗：医生现在该怎么做？

J Natl Cancer Inst. 2015 Sep 30;107(12):djv290. doi: 10.1093/jnci/djv290. Print 2015 Dec.

J Clin Oncol. 2015 Nov 20;33(33):3938-44. doi: 10.1200/JCO.2015.60.8588. Epub 2015 Sep 14.

[Radiotherapy also for good-risk ductal carcinoma in situ? Results from a prospective randomized RTOG trial].[高风险导管原位癌也采用放射治疗？来自一项前瞻性随机RTOG试验的结果]

Strahlenther Onkol. 2015 Jun;191(6):536-8. doi: 10.1007/s00066-015-0836-0.

Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.降低导管原位癌的复发率：对30年间接受保乳手术的2996名女性的分析。

Ann Surg Oncol. 2015 Oct;22(10):3273-81. doi: 10.1245/s10434-015-4740-8. Epub 2015 Jul 28.

RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.放射治疗肿瘤学组（RTOG）9804：一项针对低风险导管原位癌的前瞻性随机试验，比较放疗与观察的效果。

J Clin Oncol. 2015 Mar 1;33(7):709-15. doi: 10.1200/JCO.2014.57.9029. Epub 2015 Jan 20.

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.一种多基因表达检测方法，用于预测乳腺导管原位癌的局部复发风险。

J Natl Cancer Inst. 2013 May 15;105(10):701-10. doi: 10.1093/jnci/djt067. Epub 2013 May 2.

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.乳腺导管原位癌放射治疗随机试验综述

J Natl Cancer Inst Monogr. 2010;2010(41):162-77. doi: 10.1093/jncimonographs/lgq039.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Omission of adjuvant radiotherapy in ductal carcinoma in situ : 12 year-results of the ECOG-ACRIN E5194-trial].

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献